71 episodes

The ASCO Guidelines Podcast Series features interviews with panelists of recently published American Society of Clinical Oncology Clinical Practice Guidelines products highlighting key recommendations from the publication. Music:“Journeys” by Scott Buckley – www.scottbuckley.com.au, used under CC:BY.

ASCO Guidelines Podcast Serie‪s‬ American Society of Clinical Oncology (ASCO)

    • Medicine
    • 4.5 • 35 Ratings

The ASCO Guidelines Podcast Series features interviews with panelists of recently published American Society of Clinical Oncology Clinical Practice Guidelines products highlighting key recommendations from the publication. Music:“Journeys” by Scott Buckley – www.scottbuckley.com.au, used under CC:BY.

    Management of Dyspnea in Advanced Cancer Guideline

    Management of Dyspnea in Advanced Cancer Guideline

    An interview with Dr. David Hui from MD Anderson Cancer Center and Dr. Margaret L. Campbell from Wayne State University, co-chairs on “Management of Dyspnea in Advanced Cancer: ASCO Guideline.” This guideline outlines a hierarchical approach to dyspnea management, beginning with identifying and managing potentially reversible causes, followed by the use of non-pharmacologic interventions, and then pharmacologic interventions. Read the full guideline at www.asco.org/supportive-care-guidelines

    • 12 min
    Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update

    Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Guideline Update

    An interview with Dr. Natasha Leighl, Dr. Andrew Robinson, and Dr. Gregory Riely on “Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO and OH (CCO) Guideline Update.” This guideline provides recommendations on systemic therapy for patients with stage IV NSCLC whose cancer has driver alterations, focusing on seven targets - EGFR, ALK, ROS-1, BRAF V600e, RET, MET exon 14 skipping mutations & NTRK. Read the full guideline at www.asco.org/thoracic-cancer-guidelines.

    • 20 min
    Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline

    Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer Guideline

    An interview from Dr. Larissa A. Korde from the National Cancer Institute and Dr. Dawn L. Hershman from Columbia University on “Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.” This guideline covers the optimal use of neoadjuvant therapy for women with invasive, non-metastatic breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines.

    • 15 min
    Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement

    Radiation Therapy for Small Cell Lung Cancer Guideline Endorsement

    An interview with Dr. Megan E. Daly from the University of California, Davis on “Radiation Therapy for Small Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline.” An ASCO Expert Panel reviewed an ASTRO guideline on radiation therapy for SCLC and determined it was clear, thorough, and evidence based. ASCO endorsed the ASTRO guideline with a few discussion points, which Dr. Daly reviews in this podcast. Read the full guideline endorsement at www.asco.org/thoracic-cancer-guidelines.

    • 8 min
    Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

    Initial Management of Non-Castrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

    An interview with Dr. Katherine S. Virgo from Emory University in Atlanta, GA on “Initial Management of Non-Castrate Advanced, Recurrent or Metastatic Prostate Cancer: ASCO Guideline Update.” This guideline updates recommendations for initial hormonal management of non-castrate advanced, recurrent, or metastatic prostate cancer. Read the full guideline at www.asco.org/genitourinary-cancer-guidelines.

    • 13 min
    PREVIEW: ASCO in Action CEO & CMO Interview

    PREVIEW: ASCO in Action CEO & CMO Interview

    A preview of the interview by ASCO in Action podcast host ASCO CEO Dr. Clifford A. Hudis with retiring ASCO CMO Dr. Richard L. Schilsky examining Dr. Schilsky’s trailblazing medical career, his leadership in ASCO and indelible mark on its research enterprise, and what he sees for the future of oncology. Dr. Hudis also shares what Dr. Schilsky’s friendship & mentorship has meant to him and suggests that he will still be supporting ASCO on critical priorities. To hear more, visit podcast.asco.org

    • 1 min

Customer Reviews

4.5 out of 5
35 Ratings

35 Ratings

esg311 ,

Helpful and engaging!

Great way to keep tabs on the latest innovations in oncology, all while raising up a range of voices in the practice. And an excellent host!

&rew125 ,

Excellent and informative

This podcast is always educational, organized, and succinct. An excellent program!

NellyLoCo ,

Helpful - and short- podcasts

I think this podcast is great becuase it's usually very relevant to practicing oncologists but it's also quick. I can generally listen to it over my commute.

Top Podcasts In Medicine

Listeners Also Subscribed To